Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 79
Filtrar
Más filtros

País/Región como asunto
Intervalo de año de publicación
1.
J Dairy Sci ; 97(11): 7225-9, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25218747

RESUMEN

The objective of the present study was to evaluate the relationship between the efficiency of conversion of feed N into milk N [N-use efficiency (NUE)] and (15)N enrichment of milk casein from lactating cows fed corn silage-based diets. Samples of feeds and milk were obtained from 3 experiments with lactating dairy cows. All diets were based on corn silage and were designed to evaluate the effects of (1) diets with different ratios of effective rumen-degradable protein to fermentable metabolizable energy (experiment 1), (2) different proportions of quickly and slowly rumen-degradable protein (experiment 2), and (3) synchronizing the availability of fermentable metabolizable energy and effective rumen-degradable protein in the rumen (experiment 3). Although no significant effect of diet on casein δ(15)N values was detected, casein was more enriched than the diet in each of the experiments. Nitrogen-use efficiency was negatively related to adjusted Δ(15)N (casein δ(15)N--diet δ(15)N) for experiments 1 and 2 individually and when combining data from all 3 experiments. The relatively low values for Δ(15)N suggest that these productive animals were using dietary N efficiently, with a high proportion of N going to milk protein and less to urea. The weak, although significant, relationship between NUE and adjusted Δ(15)N, is consistent with relatively little variation in hepatic deamination and transamination, with variation in rumen efficiency having the predominant effect on NUE. The present study confirms the lower (15)N enrichment in protein when NUE is high and the potential to use N-isotope fractionation as a marker of NUE.


Asunto(s)
Alimentación Animal/análisis , Caseínas/análisis , Bovinos/fisiología , Lactancia/fisiología , Nitrógeno/química , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Caseínas/metabolismo , Dieta/veterinaria , Femenino , Fermentación , Leche/química , Proteínas de la Leche/metabolismo , Nitrógeno/metabolismo , Isótopos de Nitrógeno , Rumen/metabolismo , Ensilaje , Urea/análisis , Zea mays/metabolismo
2.
Eur J Clin Microbiol Infect Dis ; 30(4): 555-9, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21207091

RESUMEN

The purpose of this study was to evaluate the influence of adding Lactobacillus acidophilus to a triple regimen for Helicobacter pylori eradication in untreated patients with peptic ulcers or ulcer-scars. This was a pre-randomized, single-blind, interventional, treatment-efficacy study with active controls and parallel-assignment, set in Coimbra, Portugal, on 62 consecutive H. pylori-positive untreated adults with peptic ulcers or ulcer-scars, diagnosed by gastroduodenoscopy, with pre-treatment direct Gram-staining and culture of gastric biopsies. The first 31 patients received esomeprazole 20 mg, amoxicillin 1000 mg and clarithromycin 500 mg (EAC), all b.i.d., for 8 days. The remaining 31 added L. acidophilus, 5 × 10(9) organisms per capsule, 3 + 2 i.d. for 8 days (EACL). The main outcome measure was (13)C urea breath test (UBT), ≥6 weeks after completion of therapy. Successful eradication (UBT-negativity after treatment), was similar in both groups (EAC = 80.6%; EACL = 83.9%, p = 0.740) by both intention-to-treat and per-protocol analysis. The non-eradicated strains were susceptible in vitro to both antibiotics. Adding L. acidophilus to EAC triple therapy did not increase H. pylori eradication rates. Considering the cost and the burden of ingesting five extra capsules daily, supplementing the EAC therapy with L. acidophilus, at this dose, shows no benefit. Further studies with different dosages and duration of treatment, and other probiotics or probiotic combinations are required to improve eradication.


Asunto(s)
Antibacterianos/uso terapéutico , Antiulcerosos/uso terapéutico , Esomeprazol/uso terapéutico , Infecciones por Helicobacter/tratamiento farmacológico , Helicobacter pylori/efectos de los fármacos , Lactobacillus acidophilus , Probióticos/uso terapéutico , Adulto , Anciano , Anciano de 80 o más Años , Amoxicilina/administración & dosificación , Amoxicilina/uso terapéutico , Pruebas Respiratorias , Claritromicina/administración & dosificación , Claritromicina/uso terapéutico , Terapia Combinada , Quimioterapia Combinada , Esomeprazol/administración & dosificación , Femenino , Infecciones por Helicobacter/microbiología , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Úlcera Péptica/tratamiento farmacológico , Úlcera Péptica/microbiología , Probióticos/administración & dosificación , Método Simple Ciego , Resultado del Tratamiento , Urea , Adulto Joven
3.
J Dairy Sci ; 94(9): 4647-56, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21854937

RESUMEN

A cyclical changeover design experiment (3-wk periods; 12-wk total) was conducted to evaluate whether improving the balance of absorbable AA would allow the feeding of less crude protein (CP) without compromising production, thereby reducing the potential environmental pollution from dairy farms. Sixteen multiparous Holstein cows were assigned to 1 of 8 dietary treatments as total mixed rations (TMR) containing [dry matter (DM) basis] 45% corn silage, 5% coarsely chopped wheat straw, and 50% concentrate mixture. The 8 treatments were formulated to differ in dietary CP (14 and 16%; DM basis) and in the balance of absorbable AA achieved by changing the main protein source (MPS) of the concentrate mixtures [replacing soybean meal (SBM) with corn byproducts (CBP), dried corn distillers grains (DDG), and some corn gluten meal], and by adding a mixture of rumen-protected Lys and Met (RPLM). Feeding lactating dairy cows corn silage-based diets with 16% CP promoted significantly higher DM intakes and milk yields, and lower feed N-use efficiency than feeding diets with 14% CP. Replacing SBM with CBP significantly increased milk yields and decreased milk fat and protein concentrations, but had no effect on the efficiency of conversion of feed N into milk N. With 16% CP diets, the addition of RPLM decreased feed N use efficiency. A significant effect was observed for the MPS × RPLM interaction on milk protein concentrations. Plasma Lys concentration was lower with diets based on CBP, and plasma Met increased with RPLM. We did not find clear benefits of RPLM in facilitating a reduction of dietary protein without loss of production.


Asunto(s)
Aminoácidos/farmacología , Bovinos/metabolismo , Dieta/veterinaria , Proteínas en la Dieta/farmacología , Lactancia/efectos de los fármacos , Ensilaje , Zea mays , Aminoácidos/metabolismo , Animales , Proteínas en la Dieta/metabolismo , Ingestión de Alimentos , Grasas/análisis , Femenino , Lactancia/metabolismo , Leche/química , Leche/metabolismo , Proteínas de la Leche/análisis
4.
Transplant Proc ; 41(3): 855-8, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19376371

RESUMEN

Acute humoral rejection (AHR) is a severe form of rejection associated with poor graft survival. Prompt diagnosis and rapid institution of therapy are crucial to improve the prognosis. A therapeutic approach based on plasmapheresis, intravenous imunoglobulin, and rituximab seems to be effective in refractory cases. Herein we have described our experience with 11 patients with biopsy-proven AHR who were treated between January 2005 and June 2008. Seven of these patients had panel reactive antibodies titers more than 50%. The diagnosis was based on Banff 2001 criteria; treatment consisted of a combination of plasmapheresis and intravenous immunoglobulin. Four refractory cases were also treated with a single dose of rituximab. One graft was lost due to thrombosis. All other patients recovered graft function with an average creatinine level of 1.6 mg/dL at 8.6 +/- 2.7 months of follow-up.


Asunto(s)
Rechazo de Injerto/diagnóstico , Trasplante de Riñón/inmunología , Trasplante de Riñón/patología , Enfermedad Aguda , Adulto , Formación de Anticuerpos , Biopsia , Creatinina/sangre , Femenino , Rechazo de Injerto/terapia , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Enfermedades Renales/cirugía , Trasplante de Riñón/fisiología , Masculino , Persona de Mediana Edad , Plasmaféresis , Terapia de Reemplazo Renal , Estudios Retrospectivos , Factores de Tiempo , Trasplante Homólogo/inmunología , Trasplante Homólogo/patología , Adulto Joven
5.
Transplant Proc ; 41(3): 909-12, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19376386

RESUMEN

Simultaneous pancreas-kidney transplantation (SPK) is the treatment of choice for selected diabetic patients with end-stage renal disease. Maintenance steroid therapy is associated with significant morbidity and mortality among SPK transplant recipients. Steroid withdrawal regimens are becoming more common, albeit with reservations regarding its safety and efficacy. We performed a retrospective review of 77 SPK transplant recipients from May 2000 to December 2007. The subjects received induction therapy with thymoglobulin followed by maintenance immunosuppression with tacrolimus and mycophenolate mofetil. A late steroid withdrawal protocol was adopted. The rates of acute rejection, graft and patient survival, and side effects were analyzed. One-year patient, kidney, and pancreas survivals were 93%, 91%, and 86%, respectively. Eleven patients experienced acute rejection. Mean follow-up time was 1155.5 +/- 776.1 days. Prednisolone withdrawal was carried out between 6 and 12 months posttransplantation in 42 patients (77.8%) with at least 1 year follow-up; no case of acute rejection occurred. At present, 72 patients have a functioning kidney graft, and 65 patients also have a functioning pancreas graft. The mean serum creatinine is 1.12 +/- 0.49 mg/dL and the mean HbA1c concentration is 4.5% +/- 0.4%. The patients have a low prevalence of hypertension, hyperlipidemia, and obesity. Steroid withdrawal was successful and safe in the majority of in-study patients and safe without an increase of immune events. Our patient and graft outcomes are within other international SPK transplant units standards.


Asunto(s)
Corticoesteroides/uso terapéutico , Diabetes Mellitus/cirugía , Nefropatías Diabéticas/cirugía , Fallo Renal Crónico/cirugía , Trasplante de Riñón/fisiología , Trasplante de Páncreas/fisiología , Corticoesteroides/administración & dosificación , Creatinina/sangre , Esquema de Medicación , Estudios de Seguimiento , Hemoglobina Glucada/metabolismo , Humanos , Fallo Renal Crónico/etiología , Trasplante de Riñón/mortalidad , Lípidos/sangre , Trasplante de Páncreas/mortalidad , Análisis de Supervivencia , Sobrevivientes , Factores de Tiempo
6.
Transplant Proc ; 41(3): 913-5, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19376387

RESUMEN

The recurrence or persistence of pancreatic autoantibodies after pancreas-kidney transplantation (PKT) is an intriguing finding. We prospectively analyzed 77 PKTs, searching for risk factors for the expression of these autoimmune markers and their impact on pancreas graft function. Among the 77 PKTs, 24.7% had 0 HLA matches, 20.8% displayed delayed graft function, and 14.3% had acute rejection episodes. Immunosuppression included antithymocyte globulin (ATG), tacrolimus, mycophenolate mofetil (MMF), and steroids. Sixty-five patients had both grafts functioning as a follow-up of more than 6 months. In 11 patients anti-glutamic acid decarboxylase (GAD) positivity persists (n = 8) or has recurred (n = 3), 4 of whom show increasing titers. Two patients maintain positive islet cell antibodies (ICA) and anti-GAD antibodies. The 9 patients positive for ICA included 2 who were negative before PKT and 7 who remain positive. The "positive" group (22 patients with positive ICA and/or anti-GAD) did not differ from the global group of 65 functioning PKT in terms of acute rejection episodes, HLA match, and steroid withdrawal. Among the positive patients, there were 2 with borderline glucose levels; however, among the entire "positive" group, the mean fasting glucose, HbA1c, and C-peptide measurements were not significantly different, when compared with the other 65 PKTs. In conclusion, pancreatic autoantibodies may be persistently positive or recur after PKT, despite appropriate immunosuppression. Its impact on long-term pancreas graft survival is unknown. We could not identify risk factors for their expression. An extended follow-up with monitoring and search for other risk factors may be necessary to increase our knowledge in this field.


Asunto(s)
Autoanticuerpos/sangre , Diabetes Mellitus Tipo 1/cirugía , Nefropatías Diabéticas/cirugía , Fallo Renal Crónico/cirugía , Trasplante de Riñón/inmunología , Trasplante de Páncreas/inmunología , Adulto , Glucemia/metabolismo , Péptido C/sangre , Cadáver , Femenino , Estudios de Seguimiento , Hemoglobina Glucada/metabolismo , Humanos , Fallo Renal Crónico/etiología , Masculino , Persona de Mediana Edad , Páncreas/inmunología , Valores de Referencia , Estudios Retrospectivos , Donantes de Tejidos , Adulto Joven
7.
J Dairy Sci ; 92(9): 4530-40, 2009 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-19700715

RESUMEN

The effects of supplementation with rapeseed, sunflower, and linseed oils (0.5 kg/d; good sources of oleic, linoleic, and linolenic acids, respectively) on milk responses and milk fat fatty acid (FA) profile, with special emphasis on rumen-derived biohydrogenation intermediates (BI), were evaluated in a replicated 4 x 4 Latin square study using 16 grazing dairy cows. The dietary treatments were 1) control diet: 20-h access to grazing pasture supplemented with 5 kg/d of corn-based concentrate mixture (96% corn; CC); 2) RO diet: 20-h access to grazing supplemented with 4.5 kg/d of CC and 0.5 kg of rapeseed oil; 3) SO diet: 20-h access to grazing supplemented with 4.5 kg/d of CC and 0.5 kg of sunflower oil; and 4) LO diet: 20-h access to grazing supplemented with 4.5 kg/d of CC and 0.5 kg of linseed oil. Milk fatty acids were converted to methyl esters and analyzed by gas-liquid chromatography and silver-ion HPLC. Dietary treatments had no effect on milk production or on milk protein content and milk protein production. Supplementation with rapeseed and sunflower oils lowered milk fat content and milk fat production, but linseed oil had no effect. Inclusion of dietary vegetable oils promoted lower concentrations of short-chain (including 4:0) and medium-chain FA (including odd- and branched-chain FA) and 18:3n-3, and higher concentrations of C(18) FA (including stearic and oleic acids). The BI concentration was higher with the dietary inclusion of vegetable oils, although the magnitude of the concentration and its pattern differed between oils. The RO treatment resulted in moderate increases in BI, including trans 18:1 isomers and 18:2 trans-7,cis-9, but failed to increase 18:1 trans-11 and 18:2 cis-9,trans-11. Sunflower oil supplementation resulted in the highest concentrations of the 18:1 trans-10, 18:1 cis-12, and 18:2 trans-10,trans-12 isomers. Concentrations of 18:1 trans-11 and 18:2 cis-9,trans-11 were higher than with the control and RO treatments but were similar to the LO treatment. Concentration of BI in milk fat was maximal with LO, having the highest concentrations of some 18:1 isomers (i.e., trans-13/14, trans-15, cis-15, cis-16), most of the nonconjugated 18:2 isomers (i.e., trans-11,trans-15, trans-11,cis-15, cis-9,cis-15, and cis-12,cis-15), and conjugated 18:2 isomers (i.e., trans-11,cis-13, cis-12,trans-14, trans-11,trans-13, trans-12,trans-14, and trans-9,trans-11), and all conjugated 18:3 isomers. The LO treatment induced the highest amount and diversity of BI without decreasing milk fat concentration, as the RO and SO treatments had, suggesting that the BI associated with 18:3n-3 intake may not be the major contributors to inhibition of mammary milk fat synthesis.


Asunto(s)
Bovinos/fisiología , Suplementos Dietéticos , Ácidos Grasos/análisis , Leche/química , Aceites de Plantas , Rumen/metabolismo , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Bovinos/metabolismo , Industria Lechera , Ácidos Grasos Monoinsaturados , Femenino , Hidrogenación , Aceite de Linaza , Aceite de Brassica napus , Aceite de Girasol
8.
Tumori ; 95(2): 227-32, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19579870

RESUMEN

GOALS: Expression of GLUT-1 and transglutaminase 2 is increased in aggressive breast cancer, whereas claudin-1, which is expressed in normal tissues, is absent in such tumors. This experimental study was undertaken to establish the aggressiveness and prognosis of DMBA-induced mammary tumors in female Wistar rats based on the assessment of these markers. MATERIALS AND METHODS: The rats were divided into two groups, a control group (n = 70) and a chemoprevention group (n = 70). Breast tumors were induced in both groups by administration of 7,12-dimethylbenz[a] anthracene (DMBA). The chemoprevention group also received alpha-tocopherol and a solution of micronutrients containing ascorbic acid and selenium. Neoplastic lesions of both groups were randomly selected for immunohistochemical assessment of the expression of GLUT-1, transglutaminase 2 and claudin-1. RESULTS: A higher proportion of mammary tumors expressed GLUT-1 and transglutaminase 2 in the chemoprevention group. Claudin-1 expression was absent in all tumors of both groups. CONCLUSIONS: These results are suggestive of increased aggressiveness of tumors not susceptible to chemoprevention by the agents used in this study.


Asunto(s)
Anticarcinógenos/farmacología , Antioxidantes/farmacología , Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/enzimología , Neoplasias de la Mama/prevención & control , Proteínas de Unión al GTP/efectos de los fármacos , Transportador de Glucosa de Tipo 1/efectos de los fármacos , Transglutaminasas/efectos de los fármacos , 9,10-Dimetil-1,2-benzantraceno , Animales , Anticarcinógenos/administración & dosificación , Antioxidantes/administración & dosificación , Ácido Ascórbico/farmacología , Neoplasias de la Mama/inducido químicamente , Carcinógenos , Femenino , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Proteína Glutamina Gamma Glutamiltransferasa 2 , Distribución Aleatoria , Ratas , Ratas Wistar , Compuestos de Selenio/farmacología , Insuficiencia del Tratamiento , alfa-Tocoferol/farmacología
9.
Transplant Proc ; 51(5): 1575-1578, 2019 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31155195

RESUMEN

BACKGROUND: Superior patient and graft survival rates have been attributed to living donor kidney transplant (LDKT) when compared to deceased donor transplantation. The aim of this study was to assess graft survival in a population of LDKT in the last 14 years and the potential impact of some clinical features. METHODS: A retrospective observational study was conducted, reviewing the records of all patients undergoing LDKT in one center from January 1, 2004, to December 31, 2017. Survival data were evaluated by Kaplan-Meier, log rank test, and Cox regression. RESULTS: Two hundred seventy-seven LDKT were performed. The median follow-up time was 4 (0-13) years. Graft loss was observed in 9% of patients; 4 patients died. The overall survival was 97% at year 1, 94% at year 5, and 83% at years 10 and 13. We found a significantly worse graft survival in patients with early vascular complications that required surgical intervention (P = .00) ≥3 HLA MM (P = .01), ≥1 HLA-DR MM (P = .04) and female recipients (P = .01). The negative impact of ≥1 HLA-B MM on survival was borderline (P = .05). After excluding early graft losses secondary to vascular events, ≥1 HLA-A MM and rejection have also implicated a negative impact on survival (P = .04 and .01, respectively). In the multivariate analysis, these variables were still related to inferior survival. CONCLUSIONS: We observed a good overall graft survival (>80% after 13 years). Possible factors related to poor outcomes suggested by this study were early vascular complications; HLA mismatches; rejection; and, with less certainty, female recipients.


Asunto(s)
Supervivencia de Injerto/fisiología , Trasplante de Riñón/mortalidad , Donadores Vivos , Adulto , Femenino , Rechazo de Injerto/epidemiología , Antígenos HLA-DR , Prueba de Histocompatibilidad , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Estudios Retrospectivos , Análisis de Supervivencia , Factores de Tiempo
10.
J Fr Ophtalmol ; : 104241, 2024 Jul 09.
Artículo en Inglés | MEDLINE | ID: mdl-38987063
11.
Biochim Biophys Acta ; 1768(5): 1093-102, 2007 May.
Artículo en Inglés | MEDLINE | ID: mdl-17296164

RESUMEN

In the present work, we used a novel albumin-associated lipoplex formulation, containing the cationic lipid 1-palmitoyl-2-oleoyl-sn-glycero-3-ethylphosphocholine (EPOPC) and cholesterol (Chol), to evaluate the antitumoral efficacy of two gene therapy strategies: immuno-gene therapy, mediated by IL-12 gene expression, and "suicide" gene therapy, mediated by HSV-tk gene expression followed by ganciclovir (GCV) treatment. Our data show that, in an animal model bearing a subcutaneous TSA (mouse mammary adenocarcinoma) tumor, intratumoral administration of the albumin-associated complexes containing the plasmid encoding IL-12 results in a strong antitumoral effect, as demonstrated by the smaller tumor size, the higher T-lymphocyte tumor infiltration and the more extensive tumor necrotic and hemorrhagic areas, as compared to that observed in animals treated with control complexes. On the other hand, the application of the "suicide" gene therapy strategy results in a significant antitumoral activity, which is similar to that achieved with the immuno-gene therapy strategy, although involving different antineoplastic mechanisms. For the tested model, albumin-associated complexes were shown to efficiently mediate intratumoral delivery of therapeutic genes, thus leading to a significant antitumoral effect. This finding is particularly relevant since TSA tumors are characterized for being poorly immunogenic, aggressive and exhibiting high proliferation capacity.


Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Terapia Genética/métodos , Interleucina-12/administración & dosificación , Interleucina-12/genética , Neoplasias/genética , Neoplasias/terapia , Simplexvirus/enzimología , Timidina Quinasa/administración & dosificación , Timidina Quinasa/genética , Animales , Antineoplásicos , Supervivencia Celular , ADN Viral/genética , Relación Dosis-Respuesta a Droga , Femenino , Ganciclovir/uso terapéutico , Interleucina-12/metabolismo , Liposomas , Luciferasas/genética , Linfocitos Infiltrantes de Tumor/inmunología , Ratones , Ratones Endogámicos BALB C , Neoplasias/patología , Linfocitos T/inmunología , Timidina Quinasa/metabolismo
12.
Dis Esophagus ; 21(6): 570-3, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18430183

RESUMEN

SUMMARY: This study aimed to evaluate a rat model of esophageal elongation using traction sutures by the Foker's method. After esophageal division and closure of the distal segment at approximately 4 mm from the cardia, traction sutures were placed for progressive stretching until the 7(th) postoperative day in the experimental group (n = 10), whilst no traction sutures were placed in the esophagus of the control group (n = 10). Clinical outcome as well as macroscopic and microscopic esophageal morphology were evaluated in both groups. All rats survived the surgical procedure and the anesthetic recovery period. Disruption of sutures during the traction period occurred in 20% of the rats, which required reoperation. Integrity of the stretched esophagus was confirmed at autopsy in all animals. In contrast to the control group, the experimental group showed a significantly more elongated (average length 6.10 +/- 1.10 mm versus 3.91 +/- 0.17 mm, (P = 0.0001)) and thicker esophagus (average mass 35.9 +/- 3.31 mg versus 15.6 +/- 1.71 mg in the control group, P = 0.0001). Histopathological examination showed a relatively well preserved morphology of the stretched esophagus. These observations suggest that esophageal stretching by traction sutures can be undertaken reliably in a rat model, resulting in elongation and mass increase of the stretched esophagus without important tissue damage. As this model mimics Foker's method, it may serve as a useful model in further research studies and may be used to train in surgical technique.


Asunto(s)
Esófago/cirugía , Técnicas de Sutura , Tracción/métodos , Anastomosis Quirúrgica/métodos , Animales , Fenómenos Biomecánicos , Modelos Animales de Enfermedad , Femenino , Probabilidad , Distribución Aleatoria , Ratas , Ratas Endogámicas Lew , Sensibilidad y Especificidad , Estadísticas no Paramétricas , Suturas , Resistencia a la Tracción
13.
Transplant Proc ; 40(5): 1756-8, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18589188

RESUMEN

Ascites is a rare complication of renal transplantation. Ascites has been reported after kidney transplantation due to rejection, decapsulation of the graft, urinary or vascular leak, lymphocele, transudation, or infection. While technical complications of the procedure are the most frequent cause, portal hypertension and graft rejection are other causes. Ascites can occur after renal transplantation independent of kidney function. Usually, a time relation can be made between the surgical procedure and ascites development. Chylous ascites is still more uncommon; it is usually related to traumatic lymphatic injury. Drugs are rarely associated with the genesis of ascites. Sirolimus has been associated with a high rate of lymphoceles, lymphedema, and pulmonary alveolar proteinosis. The exact mechanisms remain unknown. The risk for lymphocele formation with sirolimus is 12% to 15%. Ascites is an adverse effect with an incidence between 3% and 20%, but no relation between sirolimus and chylous ascites was previously established. We present a clinical report of chylous ascites in a renal transplant patient under sirolimus therapy; our investigation pointed to sirolimus as the cause.


Asunto(s)
Ascitis Quilosa/inducido químicamente , Trasplante de Riñón/inmunología , Sirolimus/efectos adversos , Adulto , Humanos , Inmunosupresores/efectos adversos , Fallo Renal Crónico/etiología , Fallo Renal Crónico/cirugía , Trasplante de Riñón/efectos adversos , Masculino , Nefritis Hereditaria/complicaciones , Complicaciones Posoperatorias/inducido químicamente
14.
J Dairy Sci ; 91(7): 2736-43, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18565932

RESUMEN

The effects of supplementation with grass silage and replacement of some corn in the concentrate with soybean meal (SBM) on milk production, and milk fatty acid (FA) profiles were evaluated in a replicated 4 x 4 Latin square study using 16 dairy cows grazing pasture composed of ryegrass, Kentucky bluegrass, and white clover. Each experimental period lasted for 3 wk. The 4 dietary treatments were PC, 20 h of access to grazing pasture, supplemented with 6 kg/d of corn-based concentrate mixture (96% corn; C); PCSB, 20 h of access to grazing pasture, supplemented with 6 kg/d of corn- and SBM-based concentrate mixture (78% corn and 18% SBM; CSB); SC, 7 h of access to grazing pasture during the day and 13 h of ad libitum access to grass silage at night, supplemented with 6 kg/d of C concentrate; and SCSB, 7 h of access to grazing pasture during the day and 13 h of ad libitum access to grass silage at night, supplemented with 6 kg/d of CSB concentrate. The concentrate mixtures were offered twice each day in the milking parlor and were consumed completely. Grass silage supplementation reduced dietary crude protein and concentration of total sugars, and dietary SBM inclusion increased dietary crude protein concentration and decreased dietary starch concentration. Milk yield and energy-corrected milk were increased by SBM supplementation of cows with access to grass silage. Milk protein concentration was lower in cows offered grass silage, regardless of whether SBM was fed. Dietary SBM inclusion tended to increase milk fat concentration. Plasma urea N was reduced by silage feeding and increased by SBM supplementation. Supplementation with grass silage overnight could represent a useful strategy for periods of lower pasture availability. Dietary inclusion of SBM in solely grazing cows had no effects on milk production and composition, exacerbated the inefficient capture of dietary N, and increased diet cost. Grass silage supplementation affected milk FA profiles, increasing both the FA derived from de novo synthesis and those derived from rumen microbial biomass, and decreasing the sum of C18 FA (mostly derived from diet or from mobilization of adipose tissue reserves). Milk fat concentrations of conjugated linoleic acid cis-9, trans-11, vaccenic acid (18:1 trans-11), and linolenic acid (18:3n-3) were unaffected by grass silage supplementation, suggesting that partial replacement of pasture by unwilted grass silage does not compromise the dietary quality of milk fat for humans.


Asunto(s)
Bovinos/fisiología , Ácidos Grasos/análisis , Glycine max , Leche/química , Leche/metabolismo , Poaceae , Alimentación Animal , Fenómenos Fisiológicos Nutricionales de los Animales/fisiología , Animales , Bovinos/metabolismo , Estudios Cruzados , Suplementos Dietéticos , Femenino , Lactancia/metabolismo , Lactancia/fisiología , Lípidos/análisis , Ensilaje , Factores de Tiempo
15.
Lab Anim ; 42(4): 465-72, 2008 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-18782825

RESUMEN

Eighteen healthy skeletally mature (3 years old) ewes, with an average weight of 45 kg, of the Portuguese Churra da Terra Quente breed were used to evaluate the normal values of total and bone-specific isoform of alkaline phosphatase serum activities (ALP and BALP, respectively) and serum osteocalcin (OC) and their correlation with the serum minerals - calcium (Ca), phosphorus (P), magnesium (Mg) and ionized calcium (Ca(2+)). The sheep were maintained under controlled environmental conditions (constant diurnal photoperiod cycle and identical husbandry and feeding) for six weeks before the collection of the blood samples. The measurement of the total ALP and serum minerals was performed with automated biochemistry analysers using the BioMérieux kits, the serum electrolyte Ca(2+) Diametrics Medical, Inc specific cassettes and the BALP and OC METRATM kits from QUIDEL Corporation. The mean +/- standard deviation values obtained were: total ALP 90.17 +/- 85.72 U/L, BALP 15.0 +/- 5.44 U/L, ratio BALP/ total ALP 29.28 +/- 24.22, OC 13.02 +/- 1.87 ng/mL, Ca 2.57 +/- 0.37 mmol/L, P 2.13 +/- 0.42 mmol/L, Mg 1.04 +/- 0.13 mmol/L, Ca(2+) 1.29 +/- 0.04 mmol/L. Significant correlations were observed between the total ALP and Ca (r = 0.5939; P = 0.05) and OC and Ca (r = 0.5706; P = 0.05). Reference to the serum values of bone turnover parameters in sheep could be of great value in research and could provide complementary non-invasive information on the bone healing process, particularly with regard to obtaining an early prognosis of fracture healing.


Asunto(s)
Fosfatasa Alcalina/sangre , Remodelación Ósea/fisiología , Minerales/sangre , Ovinos/sangre , Animales , Biomarcadores/sangre , Calcio/sangre , Femenino , Magnesio/sangre , Osteocalcina/sangre , Fósforo/sangre , Ovinos/metabolismo
16.
Animal ; 12(9): 1827-1837, 2018 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-29284553

RESUMEN

Animal proteins are naturally 15N enriched relative to the diet and the extent of this difference (Δ15Nanimal-diet or N isotopic fractionation) has been correlated to N use efficiency (NUE; N gain or milk N yield/N intake) in some recent ruminant studies. The present study used meta-analysis to investigate whether Δ15Nanimal-diet can be used as a predictor of NUE across a range of dietary conditions, particularly at the level of between-animal variation. An additional objective was to identify variables related to N partitioning explaining the link between NUE and Δ15Nanimal-diet. Individual values from eight publications reporting both NUE and Δ15Nanimal-diet for domestic ruminants were used to create a database comprising 11 experimental studies, 41 treatments and individual animal values for NUE (n=226) and Δ15Nanimal-diet (n=291). Data were analyzed by mixed-effect regression analysis taking into account experimental factors as random effects on both the intercept and slope of the model. Diets were characterized according to the INRA feeding system in terms of N utilization at the rumen, digestive and metabolic levels. These variables were used in a partial least squares regression analysis to predict separately NUE and Δ15Nanimal-diet variation, with the objective of identifying common variables linking NUE and Δ15Nanimal-diet. For individuals reared under similar conditions (within-study) and at the same time (within-period), the variance of NUE and Δ15Nanimal-diet not explained by dietary treatments (i.e. between-animal variation plus experimental error) was 35% and 55%, respectively. Mixed-effect regression analysis conducted with treatment means showed that Δ15Nanimal-diet was significantly and negatively correlated to NUE variation across diets (NUE=0.415 -0.055×Δ15Nanimal-diet). When using individual values and taking into account the random effects of study, period and diet, the relationship was also significant (NUE=0.358 -0.035×Δ15Nanimal-diet). However, there may be a biased prediction for animals close to zero, or in negative, N balance. When using a novel statistical approach, attempting to regress between-animal variation in NUE on between-animal variation in Δ15Nanimal-diet (without the influence of experimental factors), the negative relationship was still significant, highlighting the ability of Δ15Nanimal-diet to capture individual variability. Among the studied variables related to N utilization, those concerning N efficiency use at the metabolic level contributed most to predict both Δ15Nanimal-diet and NUE variation, with rumen fermentation and digestion contributing to a lesser extent. This study confirmed that on average Δ15Nanimal-diet can predict NUE variation across diets and across individuals reared under similar conditions.


Asunto(s)
Proteínas en la Dieta , Nitrógeno , Rumiantes , Fenómenos Fisiológicos Nutricionales de los Animales , Animales , Biomarcadores , Dieta , Proteínas en la Dieta/metabolismo , Digestión , Femenino , Lactancia , Leche , Nitrógeno/metabolismo , Isótopos de Nitrógeno/análisis , Rumen , Rumiantes/fisiología
17.
Transplant Proc ; 39(8): 2489-93, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17954156

RESUMEN

New immunosuppressive drugs used in kidney transplantation decreased the incidence of acute rejection. It was hypothesized that, with their power, the importance of HLA matching was decreased. To evaluate the influence of HLA matching, immunosuppression, and other possible risk factors, we analyzed data of 1314 consecutive deceased donor kidney transplantation. We divided the patient population into 4 cohorts, according to the era of transplantation: era 1, before 1990, azathioprine (Aza) and cyclosporine (Csa) no microemulsion; era 2, between 1990 and 1995, Csa microemulsion; era 3, between 1996 and 2000, wide use of mycophenolate mofetil (MMF) and anti-thymocyte globulin (ATG); and era 4, after 2000, marked by sirolimus and tacrolimus (TAC) use. Multivariate analysis compared death-censored graft survival. Using as reference the results obtained with 0 HLA mismatches, we verified, during era 1 and era 2, an increased risk of graft loss for all of the subgroups with HLA mismatch >0. However, during era 3 and era 4, the number of HLA mismatches did not influence graft survival. Although acute rejection and delayed graft function, which decreased in the later periods, remained as prognostic factors for graft loss. Considering the immunosuppressive protocol with Csa+Aza+Pred as reference, protocols used after 1995 with Pred+Csa+ATG, with Pred+Csa+MMF, and with Pred+Tac+MMF presented better survival results. Results showed that the significance of HLA matching decreased while the results improved with the new immunosuppressant drugs. These observations support the hypothesis that the weakened importance of HLA matching may be a consequence of the increasing efficacy of the immunosuppression.


Asunto(s)
Antígenos HLA/inmunología , Prueba de Histocompatibilidad , Inmunosupresores/uso terapéutico , Trasplante de Riñón/inmunología , Adulto , Femenino , Humanos , Terapia de Inmunosupresión/métodos , Trasplante de Riñón/mortalidad , Masculino , Persona de Mediana Edad , Selección de Paciente , Estudios Retrospectivos , Análisis de Supervivencia , Sobrevivientes
18.
J Dairy Sci ; 90(3): 1429-39, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17297116

RESUMEN

Feed intake, milk production, and milk fatty acid profiles of dairy cows fed corn silage-based diets with different protein and starch concentrations were measured in a 3-period experiment in a changeover design using 12 Holstein cows. Each experimental period lasted for 3 wk. The diet fed as a total mixed ration consisted of 45% corn silage, 5% coarsely chopped wheat straw, and 50% concentrate, on a dry matter (DM) basis. The 4 treatments, formulated to be isoenergetic and to differ in concentrations of dietary crude protein (CP) and starch (DM basis), were as follows: low CP and low starch (LPLS; 14% CP and 15% starch), low CP and high starch (LPHS; 14% CP and 25% starch), high CP and low starch (HPLS; 16% CP and 15% starch), and high CP and high starch (HPHS; 16% CP and 25% starch). The LPLS treatment led to lower DM intake, milk yield, milk protein concentration, and milk lactose yield, probably due to a shortage of both rumen-degradable protein supply to rumen microbes and glucogenic nutrients to the animal. There were no differences between protein-rich diets and LPHS, suggesting that this diet satisfied the rumen-degradable protein requirements of rumen microbes and did not limit feed intake, and the increased supply of glucogenic nutrients spared AA so that the nutrient requirements of mid lactation dairy cows were met. Further increases in CP concentration increased plasma urea concentration and resulted in decreased efficiency of conversion of dietary N into milk N. Milk fatty acid profiles were affected by starch and protein supply, with starch having the largest effect. Additionally, increasing dietary starch concentration decreased the apparent transfer of dietary polyunsaturated fatty acids to milk, suggesting an increased channeling of fatty acids to adipose tissue. The results further suggest that C(15:0) and C(17:0) are synthesized de novo in animal tissues.


Asunto(s)
Bovinos/fisiología , Proteínas en la Dieta/metabolismo , Ingestión de Alimentos/fisiología , Ácidos Grasos/química , Lactancia/fisiología , Ensilaje , Almidón/metabolismo , Alimentación Animal/análisis , Animales , Bovinos/metabolismo , Industria Lechera , Dieta/veterinaria , Proteínas en la Dieta/análisis , Ácidos Grasos/fisiología , Femenino , Leche/química , Leche/metabolismo , Zea mays/metabolismo
19.
HLA ; 90(5): 267-275, 2017 11.
Artículo en Inglés | MEDLINE | ID: mdl-28776960

RESUMEN

The role of de novo donor-specific anti-human leukocyte antigen (anti-HLA) antibodies (dnDSA) within the pathways leading to graft failure remains not fully understood. We investigated 56 patients who were transplanted between 2002 and 2014 with kidney graft failure (cases), for a possible association of development of dnDSA with graft failure. The 56 patients with failed transplants were matched with 56 patients with a functioning graft at present for the variables deceased or living donor, transplant number, transplant year, recipient age and gender, donor age and gender, dialysis vintage time, transplant induction therapy. All patients had at least one serum collected 1 year before failure (in cases) or end of follow-up (in controls). Cases and controls were very well-matched in several baseline characteristics. Post-transplant anti-HLA antibodies were found in 84% of cases and only 36% of controls (P < .001), with 54% of cases and 16% of controls (P < .001) having dnDSA at time of detection. Chronic active antibody-mediated rejection was significantly more common (P < .001) in patients with dnDSA (61% vs 12%), in 53 (47%) patients that had at least one graft biopsy performed during follow-up. dnDSA was a significant risk factor (odds ratio [OR] = 6.06; P = .003) for graft failure in a multivariable conditional logistic regression model. dnDSA as a time-dependent variable, was also an independent predictor [hazard ratio (HR) = 2.46; P = .002] of graft failure in a multivariable Cox regression analysis. In both statistical approaches, only dnDSA-II (OR = 11.90; P = .006) (HR = 2.30; P = .014) was significantly associated with graft failure. Post-transplant dnDSA was clearly associated with graft loss, particularly if against HLA class II antigens. dnDSA detection should be a tool for post-transplant monitoring of kidney graft recipients, allowing for the identification of those with a higher risk of graft failure.


Asunto(s)
Anticuerpos/inmunología , Rechazo de Injerto/inmunología , Antígenos HLA/inmunología , Trasplante de Riñón , Donantes de Tejidos , Adulto , Biopsia , Estudios de Casos y Controles , Femenino , Supervivencia de Injerto/inmunología , Humanos , Riñón/patología , Modelos Logísticos , Masculino , Análisis Multivariante , Proteinuria/complicaciones , Factores de Riesgo , Resultado del Tratamiento
20.
Food Chem ; 214: 678-685, 2017 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-27507525

RESUMEN

Lathyrus cicera L. seeds are of interest for food and feed purposes. Despite the recognized antioxidant activity of the seeds, arising from the phenolic fraction, their phenolic compounds have not been studied in depth yet. Therefore, to determine the phenolics profile of these seeds, a target analysis was performed using high-performance liquid chromatography coupled to photodiode-array detection and electrospray ionization/ion trap mass spectrometry (HPLC-DAD-ESI/MS(n)). Thirty-seven glycosylated flavonoids were identified for the first time in the seeds of this species and, according to their MS fragmentation, clustered in flavonol-3-O-di-/tri-glycosides-7-O-rhamnosides and other flavonol-glycosides, and flavonol-3-O-(cinnamoyl)glycoside-7-O-rhamnosides, flavonol-3-O-(dihydrophaseoyl, cinnamoyl)glycoside-7-O-rhamnosides and flavonol-3-O-(malonyl)glycoside-7-O-rhamnosides. Glycosides of kaempferol were the main flavonoids found (10 non-acylated and 21 acylated), followed by those of quercetin (3) and those of isorhamnetin, apigenin and luteolin (1). The most abundant flavonols were identified as kaempferol-3-O-(2-hexosyl)hexoside-7-O-rhamnosides. The methodology used allowed to increase the knowledge on a relevant phytochemical class of seeds from L. cicera.


Asunto(s)
Flavonoides/análisis , Glicósidos/análisis , Quempferoles/análisis , Lathyrus/química , Cromatografía Líquida de Alta Presión , Flavonoles/análisis , Glicosilación , Hidrólisis , Espectrometría de Masas , Fenoles/análisis , Quercetina/análogos & derivados , Quercetina/análisis , Semillas/química , Espectrometría de Masa por Ionización de Electrospray
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA